Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

High diversity of invasive Haemophilus influenzae isolates in France and the emergence of resistance to third generation cephalosporins by alteration of ftsI gene.

Deghmane AE, Hong E, Chehboub S, Terrade A, Falguières M, Sort M, Harrison O, Jolley KA, Taha MK.

J Infect. 2019 Jul;79(1):7-14. doi: 10.1016/j.jinf.2019.05.007. Epub 2019 May 14.

PMID:
31100360
2.

Diagnosis of Meningococcal Infection Using Internally Controlled Multiplex Real-Time PCR.

Deghmane AE, Hong E, Taha MK.

Methods Mol Biol. 2019;1969:17-31. doi: 10.1007/978-1-4939-9202-7_2.

PMID:
30877667
3.

Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016.

Topaz N, Caugant DA, Taha MK, Brynildsrud OB, Debech N, Hong E, Deghmane AE, Ouédraogo R, Ousmane S, Gamougame K, Njanpop-Lafourcade BM, Diarra S, Fox LM, Wang X.

EBioMedicine. 2019 Mar;41:488-496. doi: 10.1016/j.ebiom.2019.02.054. Epub 2019 Mar 4.

4.

Whole genome sequencing reveals Trans-European spread of an epidemic Neisseria meningitidis serogroup W clone.

Taha MK, Deghmane AE, Knol M, van der Ende A.

Clin Microbiol Infect. 2019 Jun;25(6):765-767. doi: 10.1016/j.cmi.2018.12.030. Epub 2019 Jan 12. No abstract available.

PMID:
30641230
5.

Acquisition of Beta-Lactamase by Neisseria meningitidis through Possible Horizontal Gene Transfer.

Hong E, Deghmane AE, Taha MK.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00831-18. doi: 10.1128/AAC.00831-18. Print 2018 Sep.

6.

Analysis of the impact of corticosteroids adjuvant treatment during experimental invasive meningococcal infection in mice.

Levy M, Deghmane AE, Aouiti-Trabelsi M, Dauger S, Faye A, Mariani-Kurkdjian P, Taha MK.

Steroids. 2018 Aug;136:32-39. doi: 10.1016/j.steroids.2018.05.007. Epub 2018 May 11.

7.

Molecular Characterization of Invasive Isolates of Neisseria meningitidis in Casablanca, Morocco.

Razki A, Hong E, Zerouali K, Belabbes H, Aitmouss K, Terrade A, Zaki B, Deghmane AE, Elmdaghri N, Taha MK.

J Clin Microbiol. 2018 Jun 25;56(7). pii: e00445-18. doi: 10.1128/JCM.00445-18. Print 2018 Jul.

8.

Differential expression of hemoglobin receptor, HmbR, between carriage and invasive isolates of Neisseria meningitidis contributes to virulence: lessons from a clonal outbreak.

Sevestre J, Diene SM, Aouiti-Trabelsi M, Deghmane AE, Tournier I, François P, Caron F, Taha MK.

Virulence. 2018 Dec 31;9(1):923-929. doi: 10.1080/21505594.2018.1460064.

9.

Unusual Initial Abdominal Presentations of Invasive Meningococcal Disease.

Guiddir T, Gros M, Hong E, Terrade A, Denizon M, Deghmane AE, Taha MK.

Clin Infect Dis. 2018 Sep 28;67(8):1220-1227. doi: 10.1093/cid/ciy257.

10.

Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine.

McNeil LK, Donald RGK, Gribenko A, French R, Lambert N, Harris SL, Jones TR, Li S, Zlotnick G, Vogel U, Claus H, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Wang X, Vuong J, Mayer LW, Pride MW, Jansen KU, Anderson AS.

MBio. 2018 Mar 13;9(2). pii: e00036-18. doi: 10.1128/mBio.00036-18.

11.

Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France.

Hong E, Barret AS, Terrade A, Denizon M, Antona D, Aouiti-Trabelsi M, Deghmane AE, Parent du Châtelet I, Levy-Bruhl D, Taha MK.

J Infect. 2018 Feb;76(2):149-158. doi: 10.1016/j.jinf.2017.10.015. Epub 2017 Nov 10.

12.

Durability of immunogenicity and strain coverage of MenBvac, a meningococcal vaccine based on outer membrane vesicles: Lessons of the Normandy campaign.

Sevestre J, Hong E, Delbos V, Terrade A, Mallet E, Deghmane AE, Lemée L, Taha MK, Caron F.

Vaccine. 2017 Jul 13;35(32):4029-4033. doi: 10.1016/j.vaccine.2017.05.065. Epub 2017 Jun 16.

13.

Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.

Narni-Mancinelli E, Gauthier L, Baratin M, Guia S, Fenis A, Deghmane AE, Rossi B, Fourquet P, Escalière B, Kerdiles YM, Ugolini S, Taha MK, Vivier E.

Sci Immunol. 2017 Apr 28;2(10). pii: eaam9628. doi: 10.1126/sciimmunol.aam9628.

14.

Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies.

Rosain J, Hong E, Fieschi C, Martins PV, El Sissy C, Deghmane AE, Ouachée M, Thomas C, Launay D, de Pontual L, Suarez F, Moshous D, Picard C, Taha MK, Frémeaux-Bacchi V.

J Infect Dis. 2017 Apr 15;215(8):1331-1338. doi: 10.1093/infdis/jix143.

15.

Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015.

Parent du Chatelet I, Deghmane AE, Antona D, Hong E, Fonteneau L, Taha MK, Lévy-Bruhl D.

J Infect. 2017 Jun;74(6):564-574. doi: 10.1016/j.jinf.2017.02.011. Epub 2017 Mar 7.

PMID:
28279715
16.

Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France.

Taha MK, Hawkins JC, Liberator P, Deghmane AE, Andrew L, Hao L, Jones TR, McNeil LK, O'Neill RE, Perez JL, Jansen KU, Anderson AS.

Vaccine. 2017 Mar 13;35(11):1530-1537. doi: 10.1016/j.vaccine.2017.01.066. Epub 2017 Feb 10.

PMID:
28196734
17.

Emergence of meningococci with reduced susceptibility to third-generation cephalosporins.

Deghmane AE, Hong E, Taha MK.

J Antimicrob Chemother. 2017 Jan;72(1):95-98. Epub 2016 Oct 12.

PMID:
27733517
18.

The Phosphocarrier Protein HPr Contributes to Meningococcal Survival during Infection.

Antunes A, Derkaoui M, Terrade A, Denizon M, Deghmane AE, Deutscher J, Delany I, Taha MK.

PLoS One. 2016 Sep 21;11(9):e0162434. doi: 10.1371/journal.pone.0162434. eCollection 2016.

19.

Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015.

Kretz CB, Retchless AC, Sidikou F, Issaka B, Ousmane S, Schwartz S, Tate AH, Pana A, Njanpop-Lafourcade BM, Nzeyimana I, Nse RO, Deghmane AE, Hong E, Brynildsrud OB, Novak RT, Meyer SA, Oukem-Boyer OOM, Ronveaux O, Caugant DA, Taha MK, Wang X; Niger Response Team.

Emerg Infect Dis. 2016 Oct;22(10):1762-1768. doi: 10.3201/eid2210.160468.

20.

Transport and Catabolism of Carbohydrates by Neisseria meningitidis.

Derkaoui M, Antunes A, Nait Abdallah J, Poncet S, Mazé A, Ma Pham QM, Mokhtari A, Deghmane AE, Joyet P, Taha MK, Deutscher J.

J Mol Microbiol Biotechnol. 2016;26(5):320-32. doi: 10.1159/000447093. Epub 2016 Jul 26.

21.

Evolutionary Events Associated with an Outbreak of Meningococcal Disease in Men Who Have Sex with Men.

Taha MK, Claus H, Lappann M, Veyrier FJ, Otto A, Becher D, Deghmane AE, Frosch M, Hellenbrand W, Hong E, Parent du Châtelet I, Prior K, Harmsen D, Vogel U.

PLoS One. 2016 May 11;11(5):e0154047. doi: 10.1371/journal.pone.0154047. eCollection 2016.

22.

Use of Animal Models To Support Revising Meningococcal Breakpoints of β-Lactams.

Belkacem N, Hong E, Antunes A, Terrade A, Deghmane AE, Taha MK.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4023-7. doi: 10.1128/AAC.00378-16. Print 2016 Jul.

23.

Neisseria meningitidis Serogroup X in Sub-Saharan Africa.

Agnememel A, Hong E, Giorgini D, Nuñez-Samudio V, Deghmane AE, Taha MK.

Emerg Infect Dis. 2016 Apr;22(4):698-702. doi: 10.3201/eid2204.150653.

24.

The phosphocarrier protein HPr of Neisseria meningitidis interacts with the transcription regulator CrgA and its deletion affects capsule production, cell adhesion, and virulence.

Derkaoui M, Antunes A, Poncet S, Nait Abdallah J, Joyet P, Mazé A, Henry C, Taha MK, Deutscher J, Deghmane AE.

Mol Microbiol. 2016 Jun;100(5):788-807. doi: 10.1111/mmi.13349. Epub 2016 Mar 10.

25.

Hyperinvasive Meningococci Induce Intra-nuclear Cleavage of the NF-κB Protein p65/RelA by Meningococcal IgA Protease.

Besbes A, Le Goff S, Antunes A, Terrade A, Hong E, Giorgini D, Taha MK, Deghmane AE.

PLoS Pathog. 2015 Aug 4;11(8):e1005078. doi: 10.1371/journal.ppat.1005078. eCollection 2015 Aug.

26.

Impact of corticosteroids on experimental meningococcal sepsis in mice.

Levy M, Antunes A, Fiette L, Deghmane AE, Taha MK.

Steroids. 2015 Sep;101:96-102. doi: 10.1016/j.steroids.2015.05.013. Epub 2015 Jun 9.

27.

Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region: July 2013 to December 2014.

Aubert L, Taha M, Boo N, Le Strat Y, Deghmane AE, Sanna A, Barret AS, Lévy-Bruhl D, Vandentorren S, Parent du Châtelet I.

Euro Surveill. 2015 Jan 22;20(3). pii: 21016. No abstract available.

28.

Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis.

Lemée L, Hong E, Etienne M, Deghmane AE, Delbos V, Terrade A, Berthelot G, Caron F, Taha MK.

PLoS One. 2014 Sep 23;9(9):e107240. doi: 10.1371/journal.pone.0107240. eCollection 2014.

29.

Meningococcal carriage: the dilemma of 4CMenB vaccine.

Taha MK, Deghmane AE.

Lancet. 2014 Dec 13;384(9960):2088-90. doi: 10.1016/S0140-6736(14)60935-1. Epub 2014 Aug 18. No abstract available.

PMID:
25145776
30.

Lipocalin 2 in cerebrospinal fluid as a marker of acute bacterial meningitis.

Guiddir T, Deghmane AE, Giorgini D, Taha MK.

BMC Infect Dis. 2014 May 20;14:276. doi: 10.1186/1471-2334-14-276.

31.

[Impact of corticosteroids in the immediate management of invasive meningococcal disease associated with hyperinvasive strains of the ST-11 clonal complex in children].

Madhi F, Levy C, Deghmane AE, Béchet S, Cohen R; Groupe des pédiatres et microbiologistes de l'Observatoire national des méningites bactériennes de l’enfant; membres du CNRM, Taha MK.

Arch Pediatr. 2014 Mar;21(3):258-64. doi: 10.1016/j.arcped.2013.12.024. Epub 2014 Jan 30. French.

PMID:
24485864
32.

Draft Genome Sequence of a Neisseria meningitidis Serogroup C Isolate of Sequence Type 11 Linked to an Outbreak among Men Who Have Sex with Men.

Veyrier FJ, Hong E, Deghmane AE, Taha MK.

Genome Announc. 2013 Oct 3;1(5). pii: e00795-13. doi: 10.1128/genomeA.00795-13.

33.

Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage.

Delbos V, Lemée L, Bénichou J, Berthelot G, Deghmane AE, Leroy JP, Houivet E, Hong E, Taha MK, Caron F; B14 STOP study group.

Vaccine. 2013 Sep 13;31(40):4416-20. doi: 10.1016/j.vaccine.2013.06.080. Epub 2013 Jul 12.

PMID:
23856330
34.

Invasive serogroup w meningococcal disease in children: a national survey from 2001 to 2008 in France.

Gaschignard J, Levy C, Deghmane AE, Dubos F, Muszlak M, Cohen R, Bingen E, Faye A, Taha MK.

Pediatr Infect Dis J. 2013 Jul;32(7):798-800. doi: 10.1097/INF.0b013e31828e9e91.

PMID:
23838782
35.

Penicillin resistance compromises Nod1-dependent proinflammatory activity and virulence fitness of neisseria meningitidis.

Zarantonelli ML, Skoczynska A, Antignac A, El Ghachi M, Deghmane AE, Szatanik M, Mulet C, Werts C, Peduto L, d'Andon MF, Thouron F, Nato F, Lebourhis L, Philpott DJ, Girardin SE, Vives FL, Sansonetti P, Eberl G, Pedron T, Taha MK, Boneca IG.

Cell Host Microbe. 2013 Jun 12;13(6):735-45. doi: 10.1016/j.chom.2013.04.016.

36.

Travel-related Neisseria meningitidis serogroup W135 infection, France.

Taha MK, Kacou-N'douba A, Hong E, Deghmane AE, Giorgini D, Okpo SL, Kangah T, Dosso M.

Emerg Infect Dis. 2013 Jun;19(6):1030-2. doi: 10.3201/eid1906.120515. No abstract available.

37.

A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups.

Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Mayer LW, Wang X, Macneil JR, York L, Tan CY, Jansen KU, Anderson AS.

Pediatr Infect Dis J. 2013 Oct;32(10):1096-101. doi: 10.1097/INF.0b013e31829aa63b.

PMID:
23694830
38.

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.

Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, Serruto D, Comanducci M, Boccadifuoco G, Donnelly JJ, Medini D, Borrow R.

Lancet Infect Dis. 2013 May;13(5):416-25. doi: 10.1016/S1473-3099(13)70006-9. Epub 2013 Feb 13.

PMID:
23414709
39.

Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.

Hong E, Thulin Hedberg S, Abad R, Fazio C, Enríquez R, Deghmane AE, Jolley KA, Stefanelli P, Unemo M, Vazquez JA, Veyrier FJ, Taha MK.

Antimicrob Agents Chemother. 2013 Apr;57(4):1961-4. doi: 10.1128/AAC.02184-12. Epub 2013 Jan 28.

40.

Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?

Hong E, Giuliani MM, Deghmane AE, Comanducci M, Brunelli B, Dull P, Pizza M, Taha MK.

Vaccine. 2013 Feb 4;31(7):1113-6. doi: 10.1016/j.vaccine.2012.12.022. Epub 2012 Dec 20.

PMID:
23261039
41.

Functional impacts of the diversity of the meningococcal factor H binding protein.

Hong E, Giorgini D, Deghmane AE, Taha MK.

Vaccine. 2012 Dec 17;31(1):183-9. doi: 10.1016/j.vaccine.2012.10.072. Epub 2012 Oct 30.

PMID:
23123023
42.

Corticosteroid therapy in genotype ST-11 meningococcal infections.

Madhi F, Levy C, Deghmane AE, Béchet S, Cohen R, Taha MK; Groupe des pédiatres et microbiologistes de l’Observatoire National des Méningites; Members of the National Reference Center for Meningococci.

Pediatr Infect Dis J. 2013 Mar;32(3):291-3. doi: 10.1097/INF.0b013e31827b12cb.

PMID:
23114370
43.

A cluster of meningococcal disease caused by rifampicin-resistant C meningococci in France, April 2012.

Mounchetrou Njoya I, Deghmane A, Taha M, Isnard H, Parent du Chatelet I.

Euro Surveill. 2012 Aug 23;17(34). pii: 20254.

44.

Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac.

Caron F, Delbos V, Houivet E, Deghmane AE, Leroy JP, Hong E, Bénichou J, Taha MK.

Vaccine. 2012 Jul 20;30(34):5059-62. doi: 10.1016/j.vaccine.2012.05.051. Epub 2012 May 30.

PMID:
22658929
45.

Vaccines targeting serogroup B meningococci.

Taha MK, Deghmane AE.

Lancet Infect Dis. 2012 Aug;12(8):578-9. doi: 10.1016/S1473-3099(12)70093-2. Epub 2012 May 7. No abstract available.

PMID:
22569483
46.

Late repression of NF-κB activity by invasive but not non-invasive meningococcal isolates is required to display apoptosis of epithelial cells.

Deghmane AE, El Kafsi H, Giorgini D, Abaza A, Taha MK.

PLoS Pathog. 2011 Dec;7(12):e1002403. doi: 10.1371/journal.ppat.1002403. Epub 2011 Dec 1.

47.

Penicillin binding proteins as danger signals: meningococcal penicillin binding protein 2 activates dendritic cells through Toll-like receptor 4.

Hill M, Deghmane AE, Segovia M, Zarantonelli ML, Tilly G, Blancou P, Bériou G, Josien R, Anegon I, Hong E, Ruckly C, Antignac A, El Ghachi M, Boneca IG, Taha MK, Cuturi MC.

PLoS One. 2011;6(10):e23995. doi: 10.1371/journal.pone.0023995. Epub 2011 Oct 27.

48.

Immediate outcomes of bacterial meningitis in childhood may benefit from slow initial β-lactam infusion and oral paracetamol.

Taha MK, Deghmane AE.

Future Microbiol. 2011 Oct;6(10):1125-9. doi: 10.2217/fmb.11.103.

PMID:
22004030
49.

Experimental meningococcal sepsis in congenic transgenic mice expressing human transferrin.

Szatanik M, Hong E, Ruckly C, Ledroit M, Giorgini D, Jopek K, Nicola MA, Deghmane AE, Taha MK.

PLoS One. 2011;6(7):e22210. doi: 10.1371/journal.pone.0022210. Epub 2011 Jul 21.

50.

From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak.

Caron F, du Châtelet IP, Leroy JP, Ruckly C, Blanchard M, Bohic N, Massy N, Morer I, Floret D, Delbos V, Hong E, Révillion M, Berthelot G, Lemée L, Deghmane AE, Bénichou J, Lévy-Bruhl D, Taha MK.

Lancet Infect Dis. 2011 Jun;11(6):455-63. doi: 10.1016/S1473-3099(11)70027-5. Epub 2011 Apr 12. Erratum in: Lancet Infect Dis. 2011 Jul;11(7):495.

PMID:
21489881

Supplemental Content

Loading ...
Support Center